PMC:7396557 / 76733-77042 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T483","span":{"begin":192,"end":201},"obj":"Disease"}],"attributes":[{"id":"A483","pred":"mondo_id","subj":"T483","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"An RCT study comprised of 33 centers and 710 patients conducted by Yuanlin Song et al. showed that XBJI in combination with conventional treatment significantly improved the primary endpoint, pneumonia severity index, in patients with severe CAP (the control group vs XBJI Group, 46.33% vs 60.78%, p \u003c 0.001)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T24078","span":{"begin":259,"end":264},"obj":"Chemical"}],"attributes":[{"id":"A96343","pred":"chebi_id","subj":"T24078","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"An RCT study comprised of 33 centers and 710 patients conducted by Yuanlin Song et al. showed that XBJI in combination with conventional treatment significantly improved the primary endpoint, pneumonia severity index, in patients with severe CAP (the control group vs XBJI Group, 46.33% vs 60.78%, p \u003c 0.001)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T569","span":{"begin":0,"end":309},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"An RCT study comprised of 33 centers and 710 patients conducted by Yuanlin Song et al. showed that XBJI in combination with conventional treatment significantly improved the primary endpoint, pneumonia severity index, in patients with severe CAP (the control group vs XBJI Group, 46.33% vs 60.78%, p \u003c 0.001)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T302","span":{"begin":192,"end":201},"obj":"Phenotype"}],"attributes":[{"id":"A302","pred":"hp_id","subj":"T302","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"An RCT study comprised of 33 centers and 710 patients conducted by Yuanlin Song et al. showed that XBJI in combination with conventional treatment significantly improved the primary endpoint, pneumonia severity index, in patients with severe CAP (the control group vs XBJI Group, 46.33% vs 60.78%, p \u003c 0.001)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2191","span":{"begin":45,"end":53},"obj":"Species"},{"id":"2192","span":{"begin":221,"end":229},"obj":"Species"},{"id":"2204","span":{"begin":192,"end":201},"obj":"Disease"}],"attributes":[{"id":"A2191","pred":"tao:has_database_id","subj":"2191","obj":"Tax:9606"},{"id":"A2192","pred":"tao:has_database_id","subj":"2192","obj":"Tax:9606"},{"id":"A2204","pred":"tao:has_database_id","subj":"2204","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"An RCT study comprised of 33 centers and 710 patients conducted by Yuanlin Song et al. showed that XBJI in combination with conventional treatment significantly improved the primary endpoint, pneumonia severity index, in patients with severe CAP (the control group vs XBJI Group, 46.33% vs 60.78%, p \u003c 0.001)."}